The effective inhibitory impact of Pc(4-4) is demonstrated via abrogation of PAR2-PH-Akt association, in vitro, and ovarian cancer peritoneal growth dissemination, in vivo. This evidence concerns the gene AKT1 and ovarian carcinoma.